Send to

Choose Destination
See comment in PubMed Commons below
Risk Manag Healthc Policy. 2008;1:15-21. doi: 10.2147/RMHP.S4500. Epub 2008 Nov 24.

The costs of breast cancer in a Mexican public health institution.

Author information

  • 1Universidad Autónoma Metropolitano-Xochimilco (UAM-X), Departments: Biological Systems and Healthcare, Biological and Health Sciences Division (DCBS).


Breast cancer (BC) is the second leading cause of death as a result of neoplasia in Mexico. This study aimed to identify the direct and indirect costs of treating female outpatients diagnosed with BC at a Mexican public hospital. A cross-sectional, observational, analytical study was conducted. A total of 506 medical records were analyzed and 102 were included in the cost analysis. The micro-costing process was used to estimate treatment costs. A 17-item questionnaire was used to obtain information on direct and indirect costs. Of the 102 women with BC included in the study, 92.2% (94) were at Stage II, and only 7.8% at Stage I. Total direct costs over six months for the 82 women who had modified radical mastectomy (MRM) surgury were US$733,821.15. Total direct costs for the 15 patients with conservative surgery (CS) were US$138,190.39. We found that the total economic burden in the study population was much higher for patients with MRM than for patients with CS.


Mexican women; breast cancer; direct and indirect costs

PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Dove Medical Press Icon for PubMed Central
    Loading ...
    Write to the Help Desk